The HIF-1α-mediated metabolic switch occurs not only in cancer cells but also in immune cells in the TME, promoting the immune inhibitory macrophage M2-like phenotype of TAMs and impairing innate immunity natural killer (NK) cell activity (13). This evidence concerns the gene HIF1A and cancer.